Vitamin E alleviates renal injury, but not hypertension, during chronic nitric oxide synthase inhibition in rats

Journal of the American Society of Nephrology

Volumn 12, Issue 12, 2001, Pages 2585-2593

  Attia, D M ^a   Verhagen, A M G ^a   Stroes, E S G ^a   Van Faassen, E E ^a   Grone H J ^a   De Kimpe, S J ^a   Koomans, H A ^a   Braam, B ^a   Joles, J A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; APOCYNIN; LUCIGENIN; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; QUERCETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; VASCULITIS;

EID: 0035200268     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Chronic nitric oxide synthase inhibition model six years on
2. Induction of renal growth and injury in the intact rat kidney by dietary deficiency of antioxidants
3. Effect of vitamin E on antioxidant enzymes, lipid peroxidation products and glomerulosclerosis in the rat remnant kidney
4. Role of xanthine oxidase in passive Heymann nephritis in rats
5. Nitric oxide and oxygen radicals: A question of balance
6. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase
7. Microvascular responses to inhibition of nitric oxide production: Role of active oxidants
8. Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations
9. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension
10. Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals
11. Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats
12. Hydralazine prevents endothelial dysfunction, but not the increase in superoxide production in nitric-oxide deficient hypertension
13. Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthase inhibition
14. NADPH oxidase: An update
15. In vivo detection of radical adducts by electron spin resonance
16. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: Role of a superoxide-producing NADH oxidase
17. Effects of extracellular pH on neutrophil superoxide anion production, and chemiluminescence augmented with luminol, lucigenin or DMNH
18. Nonsuperoxide lucigenin-enhanced chemiluminescence from phospholipids and human saphenous veins
19. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: A novel mechanism underlying tolerance and cross-tolerance
20. A metalloporphyrin superoxide dismutase mimetic protects against paraquat-induced endothelial cell injury in vitro
21. Superoxide dismutase mimics prepared from desferrioxamine and manganese dioxide
22. Superoxide anion formation from lucigenin: An electron spin resonance spin-trapping study
23. Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems
24. --generating activity
25. Diphenyleneiodonium an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production
26. A central role for the endothelial NADPH oxidase in atherosclerosis
27. Superoxide excess in hypertension and aging: A common cause of endothelial dysfunction
28. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor κB mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals
29. Angiostensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells
30. Apocynin inhibits peroxynitrite formation by murine macrophages
31. Secondary prevention with antioxidants of cardiovascular disease in end-stage renal disease (SPACE): Randomised placebo-controlled trial
32. Vitamin E: Function and metabolism
33. Glomerulosclerosis in the remnant kidney is modulated by dietary α-tocopherol
34. Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-β, and glomerular size in diabetes
35. Effect of chronic renal medullary nitric oxide inhibition on blood pressure
36. Normalization ot blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: Role of nitric oxide
37. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats
38. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: Evidence for an involvement of protein kinase C
39. Dietary L-arginine and α-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms
40. Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality
41. Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition
42. Spinal cord infarcts during long-term inhibition of nitric oxide synthase